The role of lipid metabolism marks and atherogenicity index in children with GLOMERULONEFRITIS

Yakhyaeva K.Z., Iskanova G.X., Olimova R.R.

dc.contributor.author	Yakhyaeva K.Z., Iskanova G.X., Olimova R.R.
dc.date.accessioned	2022-12-09T06:23:39Z
dc.date.available	2022-12-09T06:23:39Z
dc.date.issued	2022
dc.identifier.isbn	978-1-83853-487-5 DOI
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/4741
dc.description.abstract	In recent years, the progression of chronic glomerulonephritis (CGN) has been considered from the standpoint of the impact of a complex of modifiable and nonmodifiable factors, among which special attention is paid to the high activity of the disease, systemic and intraglomerular hypertension, hyperlipidemia and proteinuria. Most often, hyperlipidemia is considered as a secondary disorder resulting from changes in the filtration function of the kidneys.	en_US
dc.language.iso	en_US	en_US
dc.publisher	England	en_US
dc.title	The role of lipid metabolism marks and atherogenicity index in children with GLOMERULONEFRITIS	en_US
dc.type	Other	en_US